• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    DIH Announces Fiscal 2024 Financial Results for the Nine Months Ended December 31, 2023

    4/29/24 6:09:54 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care
    Get the next $DHAI alert in real time by email

    NORWELL, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a leading global robotics and virtual reality ("VR") technology provider in the rehabilitation and human performance industry, today announced financial results for the nine months ended December 31, 2023, which is the third quarter of the Company's 2024 Fiscal Year, ending March 31, 2024.

    Recent Highlights

    • Revenue of $47.1 million for the nine months ended December 31, 2023, representing growth of 42.1% over the prior year period
    • Device revenue of $36.9 million, an increase of 47.3% over the prior year period; Services revenue of $8.8 million, an increase of 17.3% over the prior year period; Other revenues of $1.4 million, an increase of 129.8% over the prior year period
    • Gross Profit for the period was $23.2 million, a 27.4% increase over the prior year period
    • Adjusted EBITDA for the period was $0.5 million

    "We are excited to announce another strong quarter of company performance as we close out the first nine months of Fiscal Year 2024. We continue to see increased opportunity and positive momentum in expanding the business into new markets and geographies," said Jason Chen, Chairman and CEO of DIH. "We saw significant revenue growth over the prior year as a result of an increase in device sales and our ability to efficiently sell into Europe, the Americas and Asia. As we enter our first quarter as a publicly traded company, our focus remains on generating stakeholder value and delivering a transformative rehabilitative care model around the world."

    Financial Results for the Nine Months Ended December 31, 2023

    Revenue for the nine months ended December 31, 2023 was $47.1 million, an increase of 42% compared to the prior year period. The increase was due primarily to a higher number of devices sold, which consisted of an increase in sales to third-party customers and stronger sales volumes in Europe, the Americas and Asia.

    Changes in foreign currency exchange rates had a favorable impact on our combined net sales in the nine months ended December 31, 2023, resulting in an increase of approximately $1.7 million. This was mainly driven by fluctuations in Euro valuations throughout the period.

    Gross profit for the nine months ended December 31, 2023 was $23.2 million, a 27% increase compared to the prior period.

    Selling, general and administrative expense for the nine months ended December 31, 2023 was $19.9 million, an increase of 9% compared to the prior period. The increase was primarily due to professional service and IT costs in preparation for the business combination with Aurora Technology Acquisition Corp. (ATAK) and becoming a publicly listed company, as well as personnel-related expenses such as payroll and pension. The increase was partially offset by a decrease in bad debt allowance and overhead expenses.

    Research and development costs for the nine months ended December 31, 2023 were $5.9 million, a decrease of 1.8% compared to the prior period. The decrease was primarily due to a decrease in research and development material purchases, external consulting fees, and overhead expenses. The decrease was partially offset by an increase in personnel expenses.

    Cash and cash equivalents on December 31, 2023 totaled $2.8 million.

    About DIH Holding US, Inc.

    DIH stands for the vision to "Deliver Inspiration & Health" to improve the functioning of millions of people with disability and functional impairments. DIH is a global solution provider in blending innovative robotic and virtual reality ("VR") technologies with clinical integration and insights. Built through the mergers of global-leading niche technologies providers, DIH is positioning itself as a transformative total smart solutions provider and consolidator in a largely fragmented and manual-labor-driven industry.

    Caution Regarding Forward-Looking Statements

    This press release contains certain statements which are not historical facts, which are forward-looking statements within the meaning of the federal securities laws, for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. These forward-looking statements include certain statements made with respect to the business combination, the services offered by DIH and the markets in which it operates, and DIH's projected future results. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Forward-looking statements are predictions provided for illustrative purposes only, and projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties that could cause the actual results to differ materially from the expected results. These risks and uncertainties include, but are not limited to: general economic, political and business conditions; the inability of the parties to consummate the proposed business combination or the occurrence of any event, change or other circumstances that could give rise to the termination of the business combination agreement, failure to realize the anticipated benefits of the business combination, including as a result of a delay in consummating the potential transaction or difficulty in integrating the businesses of DIH; the inability to maintain the listing of the DIH's securities on Nasdaq; costs related to the proposed business combination; While DIH may elect to update these forward-looking statements at some point in the future, DIH specifically disclaims any obligation to do so.

    Non-GAAP Financial Measure

    DIH reports its financial results in accordance with GAAP. However, management believes that Adjusted EBITDA, a non-GAAP financial measure, provides investors with additional useful information in evaluating our performance. DIH calculates Adjusted EBITDA as net income (loss), adjusted to exclude: (1) taxes (2) interest expense (3) depreciation and amortization and (4) other non-recurring items. Adjusted EBITDA is a financial measure that is not required by or presented in accordance with GAAP. We believe that Adjusted EBITDA, when taken together with our financial results presented in accordance with GAAP, provides meaningful supplemental information regarding our operating performance and facilitates internal comparisons of our historical operating performance on a more consistent basis by excluding certain items that may not be indicative of our business, results of operations or outlook. In particular, we believe that the use of Adjusted EBITDA is helpful to our investors as they are measures used by management in assessing the health of our business, and evaluating our operating performance, as well as for internal planning and forecasting purposes. Management presented EBITDA in historical periods prior to the completion of the Business Combination with ATAK. Adjusted EBITDA is adjusted to exclude other non-recurring items such as transaction-related expenses. By providing Adjusted EBITDA, we believe we are enhancing investors' understanding of our business and the results of operations.

    Investor Contact

    Greg Chodaczek

    332-895-3230

    [email protected]





    DIH HOLDING US, INC. AND SUBSIDIARIES
    INTERIM CONDENSED COMBINED BALANCE SHEETS
    (UNAUDITED) (in thousands)
     
      As of December

    31, 2023
      As of March 31,

    2023
     
    Assets        
    Current assets:        
    Cash and cash equivalents $2,838  $5,560 
    Restricted cash  583   415 
    Accounts receivable, net of allowances of $964 and $1,771, respectively  5,556   6,079 
    Inventories, net  7,494   6,121 
    Promissory note - related party  405   — 
    Due from related party  119   7,400 
    Other current assets  7,323   5,210 
    Total current assets  24,318   30,785 
    Property, and equipment, net  676   826 
    Capitalized software, net  2,093   2,203 
    Other intangible assets, net  380   380 
    Operating lease, right-of-use assets, net  5,081   3,200 
    Deferred tax assets  252   1 
    Other assets  48   39 
    Total assets $32,848  $37,434 
    Liabilities and Equity (Deficit)        
    Current liabilities:        
    Accounts payable $5,097  $3,200 
    Employee compensation  3,155   3,678 
    Due to related party  —   7,322 
    Current maturities of long-term debt  1,135   1,514 
    Revolving credit facilities  10,311   12,976 
    Current portion of deferred revenue  6,860   8,395 
    Manufacturing warranty obligation  1,190   979 
    Current portion of long-term operating lease  1,787   1,255 
    Advance payments from customers  12,152   6,878 
    Accrued expenses and other current liabilities  13,175   12,411 
    Total current liabilities  54,862   58,608 
    Long-term debt, net of current maturities  —   489 
    Non-current deferred revenues  4,284   2,282 
    Long-term operating lease  3,319   1,970 
    Deferred tax liabilities  388   391 
    Other non-current liabilities  3,943   2,748 
    Total liabilities $66,796  $66,488 
    Commitments and contingencies (Note 15)        
    Equity (Deficit):        
    Net parent company investment  (37,140)  (32,977)
    Accumulated other comprehensive income  3,192   3,923 
    Total (deficit) $(33,948) $(29,054)
    Total liabilities and (deficit) $32,848  $37,434 
     
    See accompanying notes to the condensed combined financial statements.





    DIH HOLDING US, INC. AND SUBSIDIARIES

    INTERIM CONDENSED COMBINED STATEMENTS OF OPERATIONS
    (UNAUDITED) (in thousands)
     
      For the Nine Months Ended December 31, 
      2023  2022 
    Revenue $47,121  $33,168 
    Cost of sales  23,945   14,983 
             
    Gross profit  23,176   18,185 
    Operating expenses:        
    Selling, general, and administrative expense  19,892   18,270 
    Research and development  5,852   5,959 
    Total operating expenses  25,744   24,229 
    Operating loss  (2,568)  (6,044)
    Other income (expense):        
    Interest expense  (744)  (575)
    Other income (expense), net  (202)  690 
    Total other income (expense)  (946)  115 
    Loss before income taxes  (3,514)  (5,929)
    Income tax expense (benefit)  638   770 
    Net loss $(4,152) $(6,699)
     
    See accompanying notes to the condensed combined financial statements.





    DIH HOLDING US, INC. AND SUBSIDIARIES
    INTERIM CONDENSED COMBINED STATEMENTS OF COMPREHENSIVE LOSS
    (UNAUDITED) (in thousands)
     
      For the Nine Months Ended December 31, 
      2023  2022 
    Net loss $(4,152) $(6,699)
    Other comprehensive (loss) income, net of tax:        
    Foreign currency translation adjustments  471   538 
    Pension liability adjustments  (1,202)  (230)
    Other comprehensive (loss) income  (731)  308 
    Comprehensive loss  (4,883)  (6,391)





    DIH HOLDING US, INC. AND SUBSIDIARIES
    INTERIM CONDENSED COMBINED STATEMENTS OF CHANGES IN EQUITY (DEFICIT)
    (UNAUDITED) (in thousands)
     
      Net Parent

    Company

    Investment
      Accumulated

    Other

    Comprehensive Income (Loss)
      Total Equity

    (Deficit)
     
    Balance, March 31, 2022 $(30,503) $4,081  $(26,422)
    Net loss  (6,699)  -   (6,699)
    Other comprehensive income, net of tax  -   308   308 
    Balance, December 31, 2022 $(37,202) $4,389  $(32,813)



      Net Parent

    Company

    Investment
      Accumulated

    Other

    Comprehensive Income

    (Loss)
      Total Equity

    (Deficit)
     
              
    Balance, March 31, 2023 $(32,977) $3,923  $(29,054)
    Net loss  (4,152)  -   (4,152)
    Other comprehensive loss, net of tax  -   (731)  (731)
    Net transactions with parent  (11)  -   (11)
    Balance, December 31, 2023 $(37,140) $3,192  $(33,948)
     
    See accompanying notes to the condensed combined financial statements.





    DIH HOLDING US, INC. AND SUBSIDIARIES
    INTERIM CONDENSED COMBINED STATEMENTS OF CASH FLOWS
    (UNAUDITED) (in thousands)
     
      For the Nine Months Ended December 31, 
      2023  2022 
    Cash flows from operating activities:        
    Net loss $(4,152) $(6,699)
    Adjustments to reconcile net loss to net cash provided by operating activities:        
    Depreciation and amortization  388   93 
    Provision for credit losses  (807)  1,549 
    Allowance for inventory obsolescence  675   (205)
    (Gain) /Loss on disposal of fixed assets  (15)  (3)
    Pension contributions  (478)  (441)
    Pension (income) expense  201   (614)
    Foreign exchange (gain) loss  201   (685)
    Noncash lease expense  1,503   1,258 
    Noncash interest expense  2   177 
    Deferred income tax  (258)  (18)
    Changes in operating assets and liabilities:        
    Accounts receivable  1,316   375 
    Inventories  (1,748)  (3,054)
    Due from related parties  -   (9)
    Due to related parties  -   1,283 
    Other assets  (1,979)  (1,851)
    Operating lease liabilities  (1,425)  (1,111)
    Accounts payable  1,602   851 
    Employee compensation  (549)  13 
    Other liabilities  202   591 
    Deferred revenue  819   1,048 
    Manufacturing warranty obligation  211   (116)
    Advance payments from customers  5,573   8,037 
    Accrued expense and other current liabilities  634   1,545 
    Net cash provided by operating activities  1,916   2,014 
    Cash flows from investing activities:        
    Purchases of property and equipment  (141)  (52)
    Proceeds from sale of property and equipment  65   - 
    Capitalized software development costs  -   (13)
    Payments to related party for promissory note  (405)  - 
    Net cash used in investing activities  (481)  (65)
    Cash flows from financing activities:        
    Payments on credit facilities  (3,123)  (2,074)
    Payments on long term debt  (937)  (692)
    Net cash used in financing activities  (4,060)  (2,766)
    Effect of currency translation on cash and cash equivalents  71   (232)
    Net decrease in cash, and cash equivalents, and restricted cash  (2,554)  (1,049)
    Cash, and cash equivalents, and restricted cash - beginning of year  5,975   3,687 
    Cash, and cash equivalents, and restricted cash - end of year $3,421  $2,638 
    Cash and cash equivalents - end of year $2,838  $2,247 
    Restricted cash - end of year  583   391 
    Total cash, and cash equivalents, and restricted cash - end of year $3,421  $2,638 
    Supplemental disclosure of cash flow information:        
    Interest paid $740  $397 
    Income tax paid $-  $17 
    Supplemental disclosure of non-cash investing and financing activity:        
    Settlement of related party receivables and payables $7,322  $- 
     
    See accompanying notes to the condensed combined financial statements.





    DIH HOLDING US, INC. AND SUBSIDIARIES
    RECONCILIATION OF Non-GAAP FINANCIAL MEASURES
    (UNAUDITED) (in thousands)
     
     For Nine Months Ended December 31,

     2023  2022

    Net loss$(4,152)  $(6,699)
    Adjusted to exclude the following:      
    Taxes 638    770 
    Interest expense 744    575 
    Depreciation and amortization 388    93 
    Other non-recurring items (1) 2,837    125 
    Adjusted EBITDA$455   $(5,136)
     
    (1) Represents transaction-related expenses incurred in connection with the Business Combination with ATAK completed on February 7, 2024.



    Primary Logo

    Get the next $DHAI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DHAI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DHAI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DIH Announces Fiscal 2025 Fourth Quarter and Fiscal Year End Financial Results

    NORWELL, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced financial results for the fiscal 2025 fourth quarter and fiscal year ended March 31, 2025. Recent Highlights Revenue of $62.9 million for the fiscal year ended March 31, 2025, representing a decrease of 2.5% over the prior year Device revenue of $49.7

    10/20/25 5:05:09 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Holding US, Inc. Announces Reverse Stock Split of its Series A Common Stock

    NORWELL, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI) today announced that it will implement a reverse stock split of its Class A Common Stock, par value $0.0001 per share (the "Common Stock"), at a ratio of 1-for-25 (the "Reverse Stock Split"). The Reverse Stock Split was approved by the Company's stockholders at the Company's Special Meeting of Stockholders held on September 25, 2025, with the final ratio subsequently determined by the Company's Board of Directors on September 26, 2025. The Reverse Stock Split will take effect at market open on October 20, 2025, and the Common Stock will trade on a post-split basis on the Nasdaq Sto

    10/16/25 8:00:00 AM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Holding US, Inc. Clarifies Previous Disclosure Regarding Additional Nasdaq Staff Determination Letter

    NORWELL, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- On September 18, 2025, DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI) issued a press release disclosing that it had received a notice on September 12, 2025, from the Listing Qualifications Staff ("Staff") of the Nasdaq Stock Market LLC ("Nasdaq") that it had failed to regain compliance under Nasdaq Listing Rule 5450(b)(2)(A) (the "Bid Price Rule"), so this matter was an additional basis for delisting. The Company is clarifying that since it was not current in filing its Form 10-Q for the period ended June 30, 2025, and Form 10-K for the fiscal year ended March 31, 2025 under Nasdaq Listing Rule 5250(c)(1) (the "Reports Rule"),

    10/1/25 8:11:40 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    SEC Filings

    View All

    DIH Holdings US Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - DIH HOLDING US, INC. (0001883788) (Filer)

    11/26/25 9:32:54 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Holdings US Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Unregistered Sales of Equity Securities

    8-K - DIH HOLDING US, INC. (0001883788) (Filer)

    11/6/25 6:03:40 AM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Holdings US Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - DIH HOLDING US, INC. (0001883788) (Filer)

    10/21/25 4:45:55 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Mooney Barrett claimed no ownership of stock in the company (SEC Form 3)

    3 - DIH HOLDING US, INC. (0001883788) (Issuer)

    9/8/25 5:15:27 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    New insider Burell Scott R claimed no ownership of stock in the company (SEC Form 3)

    3 - DIH HOLDING US, INC. (0001883788) (Issuer)

    8/11/25 4:05:17 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    New insider Streppa Dennis claimed ownership of 78,022 shares (SEC Form 3)

    3 - DIH HOLDING US, INC. (0001883788) (Issuer)

    7/25/25 4:30:13 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by DIH Holdings US Inc.

    SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)

    11/14/24 6:07:49 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by DIH Holdings US Inc.

    SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)

    11/14/24 12:46:18 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D filed by DIH Holdings US Inc.

    SC 13D - DIH HOLDING US, INC. (0001883788) (Subject)

    2/20/24 5:18:47 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    Leadership Updates

    Live Leadership Updates

    View All

    DIH Announces Fiscal 2025 Fourth Quarter and Fiscal Year End Financial Results

    NORWELL, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced financial results for the fiscal 2025 fourth quarter and fiscal year ended March 31, 2025. Recent Highlights Revenue of $62.9 million for the fiscal year ended March 31, 2025, representing a decrease of 2.5% over the prior year Device revenue of $49.7

    10/20/25 5:05:09 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Appoints Barrett Mooney, Ph.D to DIH Holding US, Inc. Board of Directors

    NORWELL, Mass., Sept. 08, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Barrett Mooney, Ph.D. to its Board of Directors. Barrett Mooney, Ph.D., has an extensive track record of growing complex and manufacturing related businesses. He currently provides strategic advisory services to growing high-technology private and public compan

    9/8/25 4:46:27 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Appoints Scott R. Burell to DIH Holding US, Inc. Board of Directors

    NORWELL, Mass., Aug. 08, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Scott R. Burell to its Board of Directors. Scott R. Burell is a seasoned healthcare finance executive with over two decades of experience leading public life sciences companies through complex transactions and growth phases. Currently serving as Chief Financia

    8/8/25 8:00:00 AM ET
    $DHAI
    $MBOT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)